A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED, ESCALATING, MULTIPLE DOSE STUDY IN BIRCH-ALLERGIC SUBJECTS TO ASSESS THE ASFETY, TOLERABILITY AND PHARMACODYNAMIC EFFECTS OF INTRADERMAL ADMINISTRATION OF BIRCH-SPIRE

Registry ID

CB001

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

CIRCASSIA LTD

Start date

2015-07-24

Last update

2015-07-03

Conditions

• ALLERGIES RESPITATORY

Related clinical trials

• A SINGLE-CENTRE, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO INVESTIGATE THE RELATIVE EFFICACY AND SAFETY OF IMMUNOTHERAPY WITH SUBLIVAC FIX PHLEUM PROTENSE COMPARED TO PLACEBO IN GRASS POLLEN-ALLERGIC-PATIENTS WITH IGE-MEDIATED SEASONAL ALLERGIC RHINOCONJUNCTIVITIS."
• A MULTI-CENTRE, DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED PARALLEL-GROUP STUDY TO ASSESS THE SAFETY AND TOLERABILITY OF GRASS-SPIRE IN SUBJECTS WITH ASTHMA AND GRASS-INDUCED RHINOCONJUNCTIVITIS
• A SINGLE GROUP STUDY EVALUATING REPRODUCIBILITY OF RHINITIS SYMPTOMS INDUCED BY ALLERGEN EXPOSURE IN THE RED MAPLE TRIALS ALLERGEN CHALLENGE THEATRE (ACT) IN SUBJECTS WITH GRASS POLLEN ALLERGY
• "AN OPTIONAL FOLLOW-UP STUDY TO EVALUATE THE CONTINUED EFFICACY OF TOLERMUNE HDM IN HOUSE DUST MITE ALLERGIC SUBJECTS FOLLOWING CHALLENGE WITH HOUSE DUST MITE ALLERGEN IN AN ENVIRONMENT EXPOSURE CHAMBER."

View on source registry